199 related articles for article (PubMed ID: 32762861)
1. Pharmacoprevention of Human Immunodeficiency Virus Infection.
Yingling C; Broholm C; Stephenson S
Nurs Clin North Am; 2020 Sep; 55(3):429-444. PubMed ID: 32762861
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
Merchant RC; Keshavarz R
Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
[TBL] [Abstract][Full Text] [Related]
3. HIV-Related Training and Correlates of Knowledge, HIV Screening and Prescribing of nPEP and PrEP Among Primary Care Providers in Southeast United States, 2017.
Henny KD; Duke CC; Geter A; Gaul Z; Frazier C; Peterson J; Buchacz K; Sutton MY
AIDS Behav; 2019 Nov; 23(11):2926-2935. PubMed ID: 31172333
[TBL] [Abstract][Full Text] [Related]
4. Updates on HIV nonoccupational postexposure prophylaxis.
Koyama A; Middlebrooks L; Bullock A
Curr Opin Pediatr; 2019 Aug; 31(4):454-461. PubMed ID: 30985387
[TBL] [Abstract][Full Text] [Related]
5. HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.
John SA; Quinn KG; Pleuhs B; Walsh JL; Petroll AE
AIDS Behav; 2020 Nov; 24(11):3124-3131. PubMed ID: 32300991
[TBL] [Abstract][Full Text] [Related]
6. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Jain S; Krakower DS; Mayer KH
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
[TBL] [Abstract][Full Text] [Related]
7. HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.
Rodríguez AE; Castel AD; Parish CL; Willis S; Feaster DJ; Kharfen M; Cardenas GA; Villamizar K; Kolber M; Vázquez-Rivera L; Metsch LR
J Acquir Immune Defic Syndr; 2013 Nov; 64 Suppl 1(0 1):S68-79. PubMed ID: 24126450
[TBL] [Abstract][Full Text] [Related]
8. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
Beekmann SE; Henderson DK
Infect Dis Clin North Am; 2014 Dec; 28(4):601-13. PubMed ID: 25287589
[TBL] [Abstract][Full Text] [Related]
9. Announcement: Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016.
MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):458. PubMed ID: 27149423
[TBL] [Abstract][Full Text] [Related]
10. Current Perspectives on the Determinants of Acceptability of Pre-Exposure Prophylaxis and Nonoccupational Post-Exposure Prophylaxis among People at Risk for HIV: A Scoping Review.
Zhou L; Assanangkornchai S
Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231904
[TBL] [Abstract][Full Text] [Related]
11. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
Tanner MR; Miele P; Carter W; Valentine SS; Dunville R; Kapogiannis BG; Smith DK
MMWR Recomm Rep; 2020 Apr; 69(3):1-12. PubMed ID: 32324724
[TBL] [Abstract][Full Text] [Related]
12. Preventing HIV infection: pre-exposure and postexposure prophylaxis.
Doblecki-Lewis S; Kolber MA
IUBMB Life; 2014 Jul; 66(7):453-61. PubMed ID: 24975125
[TBL] [Abstract][Full Text] [Related]
13. Prevention Strategies Against HIV Transmission: A Proactive Approach.
Carrion AJ; Miles JD; Mosley JF; Smith LL; Prather AS; Gurley MM; Phan LD; Everton EC
J Pharm Pract; 2018 Feb; 31(1):82-90. PubMed ID: 29278971
[TBL] [Abstract][Full Text] [Related]
14. Transitioning to HIV Pre-Exposure Prophylaxis (PrEP) from Non-Occupational Post-Exposure Prophylaxis (nPEP) in a Comprehensive HIV Prevention Clinic: A Prospective Cohort Study.
Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Walach C; Placido T; Bogoch II
AIDS Patient Care STDS; 2015 Aug; 29(8):431-6. PubMed ID: 26154174
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
Heendeniya A; Bogoch II
Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
[TBL] [Abstract][Full Text] [Related]
16. Characterizing Biomedical HIV Prevention Awareness and Use Among Black Transgender Women in the United States.
Chandler CJ; Creasy SL; Adams BJ; Eaton LA; Bukowski LA; Egan JE; Friedman MR; Stall RD; Whitfield DL
AIDS Behav; 2021 Sep; 25(9):2929-2940. PubMed ID: 33606134
[TBL] [Abstract][Full Text] [Related]
17. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
Wood BR
AIDS; 2020 Mar; 34(3):481-482. PubMed ID: 31996596
[No Abstract] [Full Text] [Related]
18. What Community-Based HIV Prevention Organizations Say About Their Role in Biomedical HIV Prevention.
Smith DK; Maier E; Betts J; Gray S; Kolodziejski B; Hoover KW
AIDS Educ Prev; 2016 Oct; 28(5):426-439. PubMed ID: 27710082
[TBL] [Abstract][Full Text] [Related]
19. Nonoccupational postexposure HIV prophylaxis in sexual assault programs: a survey of SANE and FNE program coordinators.
Draughon JE; Anderson JC; Hansen BR; Sheridan DJ
J Assoc Nurses AIDS Care; 2014; 25(1 Suppl):S90-S100. PubMed ID: 24103741
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.
Aaron E; Blum C; Seidman D; Hoyt MJ; Simone J; Sullivan M; Smith DK
AIDS Patient Care STDS; 2018 Jan; 32(1):16-23. PubMed ID: 29323558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
